CXCR4 and pulmonary arterial hypertension: CXCR4 and its ligand CXCL12 have been identified in plexiform lesions of patients with advanced PAH [15], [16]._ENREF_17 However, the potential relevance of this signaling pathway for the development of lumen-obliterating pulmonary arterial lesions remains unclear.